MedTrace Logo

In This toGether R01

NCT07382765 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 750

Last updated 2026-02-03

No results posted yet for this study

Summary

The goal of this study is to assess the effectiveness of the text-based ITG intervention to promote behaviors associated with HIV prevention amongst 18-22 year-olds in Uganda.

The main questions the study aims to answer are:

1. In a twelve-month period, does the intervention increase HIV testing and use of condoms?

a. How do the different interactive elements effect this?
2. How is effectiveness different for populations based on education, sex, and location (urban/rural)? Researchers will compare the control group, with no intervention, and the three combinations of the three intervention components: quiz questions, milestone badges, and access to on-demand advice.

Participants will receive the intervention via text messages and partake in the interactive elements listed above.

Conditions

Interventions

OTHER

Level up quizzes

Participant is given weekly quiz questions on that week's texted content

OTHER

Badges

Participants can earn badges by performing activities encouraged by program

OTHER

On-demand advice

Participants have access to ITGenie/Text Buddy, which responds to keywords with preset messages

OTHER

Content

Texted information about HIV prevention

Sponsors & Collaborators

  • Makerere University

    collaborator OTHER

  • Internet Solutions for Kids Uganda

    collaborator UNKNOWN

  • National Institute of Mental Health (NIMH)

    collaborator NIH

  • Center for Innovative Public Health Research

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
FACTORIAL

Eligibility

Min Age
18 Years
Max Age
22 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2026-03-01
Primary Completion
2028-06-30
Completion
2028-06-30

Countries

  • Uganda

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07382765 on ClinicalTrials.gov